Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study

Arturo Ortiz-Álvarez1 Department of Infectious Disease, Hospital General Dr. Manuel GEA González, Mexico City, Mexico, [email protected]

Mónica A Delgado-Ramírez1 Department of Infectious Disease, Hospital General Dr. Manuel GEA González, Mexico City, Mexico, [email protected]

Montserrat Cuevas-Zúñiga1 Department of Infectious Disease, Hospital General Dr. Manuel GEA González, Mexico City, Mexico, [email protected]

Teresa Hernández-Carrera1 Department of Infectious Disease, Hospital General Dr. Manuel GEA González, Mexico City, Mexico, [email protected]

David Moncada Barrón2 Microbiology Laboratory, Hospital General Dr. Manuel GEA González, Mexico City, Mexico

Daniel Aguilar Zapata1 Department of Infectious Disease, Hospital General Dr. Manuel GEA González, Mexico City, Mexico, [email protected]

Rafael R Valdez Vázquez1 Department of Infectious Disease, Hospital General Dr. Manuel GEA González, Mexico City, Mexico, [email protected]

Juan Pablo Ramírez-Hinojosa1 Department of Infectious Disease, Hospital General Dr. Manuel GEA González, Mexico City, Mexico, [email protected]

Ana Patricia Rodríguez-Zulueta1 Department of Infectious Disease, Hospital General Dr. Manuel GEA González, Mexico City, Mexico, [email protected]Correspondence[email protected]

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.